Stocks to invest in – 13G Filing: Nantahala Capital Management and Cogentix Medical Inc (CGNT)

Stocks to invest in

In a new filing with the Securities and Exchange Commission, Wilmot B. Harkey and Daniel Mack‘s Nantahala Capital Management reported a long position in Cogentix Medical Inc (NASDAQ:CGNT). The filing showed that Nantahala owns a 10% stake in Cogentix, which contains 2.61 million shares of the company.

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Nantahala Capital Management, 0 2,609,824 0 2,609,824 2,609,824 10.0%
Wilmot B. Harkey( 0 2,609,824 0 2,609,824 2,609,824 10.0%
Dan Mack( 0 2,609,824 0 2,609,824 2,609,824 10.0%

Wilmot B. Harkey And Daniel Mack

Nantahala Capital Management

Page 1 of 7 SEC Filing



Washington, D.C. 20549



Under the Securities Exchange Act of

(Amendment No.)*

Cogentix Medical, Inc.

(Name of Issuer)

Common Stock, par value $0.01 per share

(Title of Class of Securities)


(CUSIP Number)

January 31, 2016

(Date of Event which Requires Filing of
this Statement)

Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:

x  Rule 13d-1(b)
¨  Rule 13d-1(c)
¨  Rule 13d-1(d)

*The remainder of this cover page shall
be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any
subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required on the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).

Continued on following pages

Page 1 of 7 Pages

Follow Cogentix Medical Inc (NASDAQ:CGNT)

Biotech Insider Alert – $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund’s #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it’s sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

– Stocks to invest in

Start trading now on the best platform on the market.

Source link